The unique association of CD4+ T-lymphocyte FKBP51 expression with asthma morbidity among obese participants is consistent with CD4+ T-lymphocytes being central to the pathophysiology of asthma (29); however, molecular targets are currently limited to those in the Th2 pathway (30). This evidence concerns the gene FKBP5 and asthma.